APIIC and its partners have been awarded $14 million in federal funding to lead the development and domestic production of three critical APIs used in the treatment of asthma, diabetes and anxiety disorders.
LATEST IN Mallinckrodt Specialty Generics
UMSL partnering with API Innovation Center to help secure and strengthen the supply chain for essential pharmaceuticals in U.S.
APIIC and its partners have been awarded $14 million in federal funding to lead the development and domestic production of three critical APIs used in the treatment of asthma, diabetes and anxiety disorders.
UMSL partnering with API Innovation Center to help secure and strengthen the supply chain for essential pharmaceuticals in U.S.
APIIC and its partners have been awarded $14 million in federal funding to lead the development and domestic production of three critical APIs used in the treatment of asthma, diabetes and anxiety disorders.
UMSL awarded $2.4 million grant to continue expanding Succeed Program
The funding will go toward enhancing Succeed programming, strengthening vocational and academic opportunities and improving transition services.
MORE IN Mallinckrodt Specialty Generics
LATEST NEWS
- UMSL awarded $2.4 million grant to continue expanding Succeed Program
- Finance Career Conference offers students opportunity to lead panel, fireside chat sessions
- UMSL Global International Fellowship helps faculty members deepen their research and enrich their teaching
- Eye on UMSL: Tree time
- UMSL Tritons weekly rewind
- Nursing Assistant Teaching Professor Joshua Minks helps support doctoral nursing students through Jonas Scholar Alumni Council
- Information systems student Matt Garland already working as QA analyst at Weissman
- Student Investment Trust portfolio eclipses $1 million plateau
- UMSL Addiction Science Team’s research shows overdose deaths declining in Missouri for second straight year
- Eye on UMSL: Candlelight concert
